Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia

C Barahona-Dussault1, B Benito, O Campuzano

  • 1Institut de Cardiologie de Montréal, Montréal, Québec, Canada.

Clinical Genetics
|October 30, 2009
PubMed

Insights

Genetic testing aids arrhythmogenic right ventricular cardiomyopathy (ARVC/D) diagnosis, especially for uncertain cases. Novel mutations are common, limiting known mutation screening, but specific variants influence disease severity.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a heritable heart muscle disease.
  • Diagnostic challenges exist, particularly in individuals not fully meeting established criteria.
  • Genetic factors are implicated in ARVC/D pathogenesis.

Purpose of the Study:

  • To evaluate the utility of genetic testing in diagnosing ARVC/D.
  • To explore the role of genetic variations in ARVC/D phenotype.
  • To assess the value of screening for known mutations versus broader genetic approaches.

Main Methods:

  • Cohort study of patients with confirmed or suspected ARVC/D.
  • Genetic testing including analysis of known and novel mutations.
  • Correlation of genetic findings with clinical phenotype and disease severity.

Main Results:

  • Genetic testing is valuable for confirming ARVC/D, especially in borderline cases.
  • A high proportion of novel mutations are identified, suggesting limited utility of known mutation screening alone.
  • Specific genetic variations, including compound mutations and the P366L polymorphism, are associated with disease phenotype and severity.

Conclusions:

  • Genetic testing is a crucial tool for ARVC/D diagnosis and family screening.
  • Focusing solely on known mutations is insufficient due to the prevalence of novel variants.
  • Genetic variations significantly influence the clinical presentation and prognosis of ARVC/D patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.